Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07102966 · ClinicalTrials.gov registry record · NA
Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas
A NA study of Rare Diseases, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 410
- Enrollment target
- 1
- Study location
NCT07102966 is a NA study of Rare Diseases that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 410 participants, below the 17,417-participant average among 7 other Rare Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07102966, a NA study of Rare Diseases, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 410 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to provide advanced genetic testing and virtual consultations for seriously ill newborns in hospitals in Texas with fewer resources, especially along the Texas-Mexico border. The researchers also want to know how well the virtual consultation tool, called Consultagene, works in these hospitals by gathering feedback from healthcare providers. Researchers will provide rapid whole genome sequencing (WGS) to 200 infants over a period of 5 years. Data will be collected via Consultagene, surveys, and qualitative interviews.
Conditions Studied
Interventions
- GENETIC Rapid whole genome sequencing
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2025-10-28 |
| Est. Completion | 2029-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07102966
The ClinicalTrials.gov registry entry for NCT07102966 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 410 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 17,417-participant average among 7 other Rare Diseases trials with a reported enrollment target (98% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rare Diseases appearing as the primary indexed condition, and to 1 intervention - of which Rapid whole genome sequencing is the first listed.
NCT07102966 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07102966 about?
NCT07102966 is a clinical study titled "Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas". The purpose of this study is to provide advanced genetic testing and virtual consultations for seriously ill newborns in hospitals in Texas with fewer resources, especially along the Texas-Mexico border. The researchers also want to know how well the virtual consultation tool, called Consultagene, w...
What is the current status of trial NCT07102966?
This trial is currently recruiting. It is a NA study. The enrollment target is 410 participants. The study started on 2025-10-28. Estimated completion is 2029-07-31.
What conditions does trial NCT07102966 study?
This clinical trial studies the following conditions: Rare Diseases.
What interventions are being tested in trial NCT07102966?
The interventions under investigation include: Rapid whole genome sequencing (GENETIC).
Who is sponsoring clinical trial NCT07102966?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07102966 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rare Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants
COMPLETED · NA
-
Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)
RECRUITING · Phase 2
-
Longitudinal Studies of Patient With FPDMM
RECRUITING
-
Baker Gordon Syndrome Natural History Study
RECRUITING
-
UW Undiagnosed Genetic Diseases Program
RECRUITING
-
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.